A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
* Serum transaminases \< 2.5 x upper limits of normal
* Normal serum bilirubin
* PT/PTT/INR \< 1.5 x institutional ULN
* O2 saturation \> or = 92 %
Patients must be 19 years or older and must have signed informed consent
You may not be if
Patients with epithelial tumors of low malignant potential, stromal tumors and germ cell tumors of the ovary are ineligible to participate in the study.
Patients with the only site of disease located beyond the abdominal cavity are ineligible to participate in the study.
Patients who are pregnant or lactating are ineligible to participate in the study.
Patients with a GOG performance status of 3 or 4 are ineligible to participate in the study.
Patients with active heart disease (characterized by angina, unstable arrhythmia, congestive heart failure or EF \< 55%, pulmonary hyper- tension, active or chronic debilitating pulmonary disease(i.e., active pneumonia, severe COPD, pulmonary edema, O2 saturation \< 92%), or coagulation disorders (i.e. bleeding disorders, or on therapeutic anti- coagulants)